Allogene Therapeutics, Inc. (ALLO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 302.25M |
| Enterprise Value | 333.82M |
| P/E Ratio | -2.73 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.81 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.44 |
| Return On Equity | -0.56 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -12.36M |
| EBITDA | -177.45M |
| Net Income | -190.89M |
| Diluted EPS | -0.87 |
| Total Cash | 266.89M |
| Total Cash/Share | 1.11 |
| Total Debt | 81.05M |
| Total Debt/Equity | 0.29 |
| Current Ratio | 9.65 |
| Book Value Per Share | 1.16 |
| 52-Week Change | 72.13 |
| 52-Week High | 4.46 |
| 52-Week Low | 0.98 |
| Moving Average 50 Days | 2.15 |
| Moving Average 200 Days | 1.76 |
| Average Volume | 10.26M |
| Shares Outstanding | 243.87M |
| % Held by Institutions | 83.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |